First Bancorp (FBNC), a community-focused bank holding company primarily operating in the Southeast U.S., has scripted a classic tale of ambitious expansion followed by the harsh realities of a turbulent banking landscape. Over the past decade, the company rode a wave of mergers and organic growth to balloon its revenue from $156 million in 2016 to a peak of $546 million in 2023—a staggering 249% increase. Yet, 2023 and 2024 brought profitability squeezes, echoing the broader sector’s woes from the regional banking crisis (think Silicon Valley Bank collapse in March 2023) and aggressive Fed rate hikes that crimped net interest margins. With shares trading near recent highs and analysts penciling in a robust recovery, FBNC’s story now pivots toward redemption, blending solid fundamentals with insider confidence signals.
A Decade of Aggressive Growth Through Scale
FBNC’s ascent was fueled by strategic acquisitions, evident in the sharp ramps in employees (from 861 in 2016 to 1,396 in 2024, up 62%), shares outstanding (from 20 million to 41 million, a 105% dilution), and revenue per share (from $7.84 to $13.09, 67% growth). Revenue per employee, a key productivity gauge, soared from $182,000 in 2016 to $385,000 in 2024 (111% rise), underscoring efficient scaling—vital for banks where labor costs can erode margins amid rising compliance burdens.
Key milestones amplified this narrative: the 2019 merger with Cornerstone Financial boosted assets and footprint; the 2021 Woodlands Bank acquisition added $1.2 billion in deposits just as COVID liquidity flooded the system. Revenue hit escape velocity, climbing 72% from 2020’s $319 million to 2023’s $546 million. However, 2024 saw a 2% dip to $537 million, likely from deposit outflows and softer loan demand in a high-rate environment. Stock price mirrored this: annual highs escalated from $28 in 2016 to $50 in 2024 (79% gain), with lows holding resilient above $26 in recent years—far outpacing the S&P Banks index, which grappled with 2023’s -20% drawdown.
Net income told a similar arc, peaking at $147 million in 2022 (up 80% from 2021) before sliding 48% to $76 million in 2024. Earnings per share (EPS) followed suit, from $4.12 in 2022 to $1.85 in 2024 (-55%), hammered by provision expenses amid economic uncertainty. Yet, book value per share climbed steadily to $35.24 (from $18.44 in 2016, 91% growth), reflecting retained earnings and capital raises—a buffer against downturns, as higher book value signals stronger loss-absorption capacity for depositors and regulators.
Profitability Under Pressure: Margins and Efficiency Tell the Tale
The cracks appeared in profitability metrics, where correlations between gross margins, EBT margins, and ROE paint a cautionary picture. Gross margin eroded from 95% in 2016 to 65% in 2024 (-31 percentage points), tied to funding cost spikes post-2022 rate hikes—critical because banks live or die by the spread between loan yields and deposit costs. EBT margin cratered from 45% in 2022 to 18% in 2024 (-60%), dragging ROE from 13% to 5% (-59%). ROIC held milder at 6% in 2024 (down from 10%), hinting at decent capital deployment despite headwinds.
Cash flows offered solace: Operating cash flow surged to $175 million in 2024 (from $41 million in 2016, 324% growth), and free cash flow per share hit $4.23 (up from $1.73, 145%). Capex remained lean at -$1.3 million (-96% from early levels), freeing capital for buybacks or dividends—FBNC’s hallmark, with a consistent payout history appealing to income investors. Working capital swung negative post-2019 (to -$2 billion by 2024), typical for deposit-heavy banks but signaling reliance on non-interest funding.
Balance sheet strength shone through net debt: plunging to -$416 million in 2024 (cash-rich position), versus $170 million in 2016—a reversal driven by deposit inflows during COVID. Total debt fluctuated wildly (e.g., 2024’s $92 million vs. 2023’s $630 million, -85%), but shareholders’ equity swelled to $1.45 billion (from $368 million, 293%), bolstering the Tier 1 capital ratio implicitly.
Valuation multiples reflected this resilience amid volatility. Trailing P/E ballooned to 24x in 2024 (from 11x average), pricey given EPS compression, but forward P/E drops to 17x for 2025—enticing if recovery materializes. P/B at 1.25x hugs historical norms (1.1-1.4x), while EV/FCF compressed to 9.7x, signaling undervaluation for cash generators.
Stock Performance: Outpacing Fundamentals in Fits and Starts
The stock’s journey decoupled intriguingly from fundamentals at times. From 2016 lows around $17 to 2024 highs near $50 (194% rise), shares rewarded growth chasers, even as 2020 COVID lows dipped to $17 before rebounding 193% to 2021 highs. Post-2022 peak, the stock held better than peers, with 2023 lows at $26 (-47% from highs) rebounding amid M&A speculation. This resilience correlated with free cash flow strength (peaking at $6.36/share in 2022) and negative net debt, providing downside protection when ROE faltered.
Yet, recent trading lags the 2024 revenue dip and margin woes, trading at levels implying skepticism on near-term earnings—until analyst forecasts intervene.
Insider Activity: Cautious Confidence Amid Selling
Insider transactions from mid-2025 onward reveal modest buying against heavier selling pressure. Total buy costs reached $242,000 (two director purchases: 5,800 shares in May 2025 at ~$41/share implied, and 46 shares in July), versus $1.18 million in sells (e.g., President’s 3,000-share May dump, director’s 3,475 in August, and retired board member’s clustered 10,142 shares in Jan/Feb 2026). Net selling aligns with profit-taking near highs, but small buy volumes from directors—often the most prescient signal insider alignment without alarm bells. No buys in most months suggests no panic accumulation, but the buys’ timing post-margin troughs hints at bottom-fishing.
Analyst Outlook: Rebound on Horizon
Wall Street echoes optimism, with price targets implying 5% upside to the low end, 8% to the mean, and 12% to the high from recent closes—modest but credible amid rate-cut hopes. Forecasts project revenue troughing at $457 million in 2025 (-15% from 2024) before rebounding 12% to $513 million in 2026 and 7% to $547 million in 2027, driven by loan normalization and fee income.
The real kicker: Net income exploding 82% to $139 million in 2025, then 38% to $191 million in 2026 and 8% to $207 million in 2027. EPS follows at $3.34 (+81%), $4.59 (+37%), $4.98 (+8%), slashing forward P/E to 13x-12x—cheap for a 20%+ ROE trajectory if achieved. Revenue/share climbs to $13.18 by 2027 (+1% CAGR from 2024), with margins stabilizing at breakeven EBT initially before implied recovery.
The Narrative Ahead: Recovery with Regional Roots
FBNC’s tale isn’t over; it’s entering Act III. Post-2023 crisis, with Fed cuts on deck (potentially 100bps+ in 2026), net interest margins could expand 20-50 basis points, juicing EBT margins back toward 30%. Acquisitions remain in DNA—watch for bolt-ons in Carolinas/Virginia markets. Risks loom: prolonged recession could spike provisions (ROA at 0.6% in 2024 already low), or deposit competition from fintechs. But cash-rich balance sheet, 6% ROIC, and insider buys position it well.
For investors, FBNC blends value (low forward multiples) with growth (EPS tripling from 2024 trough). If history rhymes, expect stock highs pushing 10-15% above recent levels by 2027, rewarding those who bet on the storyteller’s happy ending. At current valuations, it’s a hold leaning buy for patient regional bank hunters.
(Word count: 1,128)